Amy D. Ozier PhD, RD, LDN, CHES

Friday June 24, 4:15–6:15 pm, Room 224

Among the many highlights of the 70th Scientific Sessions are the final results of the ACCORD trial. The story from this study continues to add to our understanding of the relationship between glucose control, microvascular complications, and cardiovascular risk. No doubt this story will continue to unfold, and the ACCORD Symposium on the final day of this year’s meeting will be highly anticipated.

Results of the ACCORD Clinical Trial

Tuesday, June 29 – Valencia Ballroom AB/CD
Chair: Denise Simons-Morton, MD, PhD

10:15 a.m.–10:35 a.m. Main Results of the ACCORD Blood Pressure Trial
William C. Cushman, MD

10:35 a.m.–10:55 a.m. Main Results of the ACCORD Lipid Trial
Henry N. Ginsberg, MD

10:55 a.m.–11:15 a.m. Effect of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes after 5 Years of Total Follow-Up
Hertzel C. Gerstein, MD

11:15 a.m.–11:35 a.m. Effect of Intensive Glycemia Treatment on Development and Progression of Microvascular Outcomes in the ACCORD Trial
Faramarz Ismail-Beigi, MD, PhD

11:35 a.m.–11:55 a.m. Effects of Intensive Glycemia and Blood Pressure Treatment and Dyslipidemia Management with Fenofibrate on Progression of Diabetic Retinopathy in the ACCORD Trial
Emily Y. Chew, MD

This year’s sessions also bring a renewed focus on scientific and clinical issues in type 1 diabetes, ranging from transplantation to immunology to the artificial pancreas. In collaboration with the JDRF, the ADA will be hosting a symposium on the developments in closed loop insulin delivery systems (the artificial pancreas) and highlighting work with continuous glucose monitoring and care delivery for those with type 1 diabetes.

Joint ADA/JDRF Symposium—The Artificial Pancreas—A Goal within Reach?

Sunday, June 27 – Room 311
Co-Chairs: Richard M. Bergenstal, MD and Richard A. Insel, MD

2:00 p.m.–2:20 p.m. Are We Closer to Closing the Loop?
Aaron Kowalski, PhD

2:20 p.m.–2:40 p.m. Landmark Continuous Glucose Management Trials—Findings and Implications for Care
William V. Tamborlane, MD

2:40 p.m.–3:00 p.m. Barriers to Continuous Glucose Management Use
Marilyn D. Ritholz, PhD

3:00 p.m.–3:20 p.m. Progress—Results of Overnight Closed-Loop Studies
Roman Hovorka, PhD

3:20 p.m.–4:00 p.m. Questions and Answers

Other notable presentations and highlights include the annual ADA/The Lancet Symposium, discussions of diabetes epidemiology, lipid management in diabetes (just how important is HDL cholesterol?), the role vitamin D plays in type 2 diabetes, and the impact of health reform on diabetes care delivery, to name just a few. As always, we will highlight our national award recipients- those that have served the ADA scientific, clinical and volunteer communities-and we invite you to join us in celebrating their accomplishments.

Joint ADA/The Lancet Symposium

Saturday, June 26 – Valencia Ballroom AB

Co-Chairs: Lin Guo, MPhil and M. Sue Kirkman, MD

8:00 a.m.–8:20 a.m. Diabetes, Fasting Glucose, and Risk of Vascular Disease—A Collaborative Meta-Analysis of 96 Prospective Studies
Nadeem Sarwar, MBBS, MPhil

8:20 a.m.–8:40 a.m. Prandial Inhaled Insulin Plus Basal Insulin Glargine vs. Pre-Mixed Biaspart Insulin for Type 2 Diabetes—A Multicentre Randomised Trial
Daniel L. Lorber, MD

8:40 a.m.–9:00 a.m. Efficacy and Safety of Exenatide Once Weekly vs. Sitagliptin or Pioglitazone as an Adjunct to Metformin for Treatment of Type 2 Diabetes (DURATION-2)—A Randomised Trial
Richard M. Bergenstal, MD

9:00 a.m.–9:20 a.m. Once-Weekly Exenatide Compared with Insulin Glargine Titrated to Target in Patients with Type 2 Diabetes (DURATION-3)—An Open-Label Randomised Trial
Michaela Diamant, MD, PhD

9:20 a.m.–9:40 a.m. Effect of Dapagliflozin in Patients with Type 2 Diabetes Who have Inadequate Glycaemic Control with Metformin—A Randomised, Double-Blind, Placebo-Controlled Trial
Clifford J. Bailey, MD, PhD

9:40 a.m.–10:00 a.m. Vitamins C and E for Prevention of Pre-Eclampsia in Women with Type 1 Diabetes (DAPIT)—A Randomised Placebo-Controlled Trial
David R. McCance, MD

There are many other presentations and symposia that have grabbed our attention, including programs on diabetes prevention. We hope to gain additional insight into exactly how successful programs like the Diabetes Prevention Program (DPP) can be put in place in our everyday world. We are seeing a great deal of new work on implementation of DPP style interventions, in a wide array of community settings.

We hope you can join us for all or part of this year’s program and sample from more than 140 symposia (featuring over 300 nationally and internationally recognized speakers) and over 2,000 individual abstract presentations. From the Opening Reception at Walt Disney World’s Epcot theme park to our Presidential Poster Session, there’s something for everyone in this year’s program.

Andrew F. Stewart, MD Chair, Scientific Sessions Meeting Planning Commitee	David Kendall, MD Chief Scientific & Medical Officer American Diabetes Association

I plan to discuss the evidence for the co-occurrence and also discuss the rather controversial area of whether patients with Type I diabetes and even their family should be routinely screened for celiac disease. If so, how is that best done and how that might affect their general health? Should we test for genetic risk for celiac disease?

Joseph A. Murray, MD
Professor of Medicine and Immunology
Mayo Clinic
Rochester, MN

Look for this Sunday morning symposia between 8:00 a.m. – 10 a.m.

A 21st Century Look at Genetic Causes of Diabetes and Its Complications in Youth

Newly Identified Causes of Monogenic Diabetes in Youth— Should a Genetic Counselor Be a Member of the Pediatric Diabetes Team?
Pal R. Njolstad, MD, PhD

A New Look at Celiac Disease—Should We Be Doing Genetic Testing?
Joseph A. Murray, MD

Genetic Protection or Genetic Predisposition for Long Term Complications of Type 1 Diabetes.
Andrzej S. Krolewski, MD, PhD

Protean Effects of Neonatal Diabetes—An Update of Treatments and Outcomes.
Michel Polak, MD, PhD

Making a Choice

If you’re not sure where to stay? Check out our Guide to the Orlando Hotels for suggestions.

Shuttle Bus Transportation

Attendees who reserve their room through CMR, will receive a shuttle pass upon check-in at their hotel. This enables them to ride the ADA shuttle system at no additional cost. Those who reserve rooms through other means can purchase a pass onsite at the meeting and in advance through the registration site for $50 per person. The pass is valid for the duration of the meeting. 

Here is a list of the Preliminary Shuttle Routes.  A final schedule will be available at your hotel and at the Orange County Convention Center.

Have questions?

Visit the Hotel and Travel website or:
Contact our ADA Housing Customer Care Center
Monday-Friday, 9:00am-9:00pm (ET)
(866) 290-9910 (Toll Free U.S. and Canada)
(415) 268-2086 (Outside U.S. and Canada)
ada2010housing@cmrus.com

This system is based on 4 principles:

Simplicity
Need no special training
Economical
Effective

Conventionally, health education is rendered through literature and lectures, which are often boring and ineffective. Different diabetes patients need different education.

We at L.K.Diabetes Centre, Indiranagar, Lucknow produce different set of films. We have classified films based on type, duration and complication of diabetes. We display them in the waiting room of our diabetes centre, during diabetes camps and distribute amongst doctors through diabetes associations. We make these films using mobile phones (Mobi−films) so that we may forward these education films as MMS (Multimedia Messaging Service) from one mobile phone to another.

We organize workshops where we train colleagues in making mobi-films. Doctors make mobi-films to educate patients and colleagues.

Patients make mobi-films to record their activities (self insulin administration at home/ diet intake etc) and show them to doctor/educator during their visit so that mistakes can be corrected.

Making these films only requires a basic mobile phone to take pictures/videos/audio. Then shift these to computer software Windows Movie Maker (available free in all computers using Windows XP). Patients should be involved in script writing and acting. Then align the pictures/videos/audio in the timeline of the software. Basic editing and background music should be added to add some spice. Cheers! A health care film is ready.

I represented India in a contest called Mobile Film Makers 2006 organized by Discovery TV Channel and NOKIA. My Mobi−films on diabetic foot care were selected in top 14 from Asia−Pacific region and I was selected as Nokia Ambassador!

L.K.Diabetes Centre is the first private exclusive diabetes centre of North India, established 18 years ago by Dr. Lakshmi Kant Shankhdhar.

Kshitij Shankhdhar is a diabetologist and diabetic foot care expert at Lucknow Diabetic Foot Care Clinic and Research Centre, LK Diabetes Centre, Indiranagar, Lucknow, India. Lakshmi Kant Shankhdhar is an endocrinologist and takes care of the Thyroid and Obesity Unit at LK Diabetes Centre. Uma Shankhdhar is a medical nutrition therapist and managing director of LK Diabetes Centre. Smita Shankhdhar is a diabetes educator and is in charge of the Diabetes Prevention Unit at LK Diabetes Centre.

Kshitij Shankhdhar – Sunday, June 27, 2010
Presentation: Diabetes Education Using Cell Phone Mobi Films
Session: New Technologies for Diabetes Education
BM-SY15 (2:00 PM – 4:00 PM) Time: 3:00 PM – 3:30 PM
Location: Orange County Convention Center, Room 208
consultantdiabetologist@gmail.com

What do you think of this approach? Do you have a similar idea to share?

The blog will give speakers and the meeting planning committee a chance to give their perspective on some of the highlights of the meeting, to share tips on traveling to Orlando, or even what restaurants you shouldn’t miss.  We hope this will be a fun, engaging opportunity to get ready for an enlightening and entertaining meeting.

Our upcoming meeting will be attended by thousands of members of the diabetes community from around the world. The program was developed by the Scientific Sessions Meeting Planning Committee, chaired by Dr. Andrew F. Stewart.

In addition, over 300 health professionals and scientists reviewed more than 2,800 abstracts, with over 2,000 abstracts selected for oral and poster sessions. These presentations represent the highest quality research in diabetes today.

This year’s program has eight theme areas focusing on the latest in basic, clinical, behavioral, public health, and educational research. Each day’s schedule includes concurrent symposia, state-of-the-art lectures, current issues, and oral and poster presentations.

West Building of the Orange County Convention Center

During the meeting the Association will honor the recipients of its highest National Scientific & Health Care Achievement Awards, and special lectures will be presented. Please join us in congratulating them on their outstanding achievements. See a complete listing of the Association’s 2010 National Achievement Award recipients.

New this year: the program will include Guided Audio Poster Tours. Moderators will lead attendees on one-hour tours of select posters, sharing their perspectives and highlighting novel or recent developments in question and answer sessions with poster presenters. Additionally, we have brought back the Presidents Poster Session and Reception on Sunday evening. This prestigious session will showcase 100 abstracts.

Plan to visit the Exhibit Hall where over 150 companies will be showcasing information, devices, supplies, and pharmaceuticals for diabetes care and management. We strongly urge you to take full advantage of this broad-based, state-of-the-art exhibition. As always, we are grateful for the generous support from our corporate partners.

Again, we welcome you to what promises to be an exciting, informative, and educational event.